优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301166 优宁维

已收盘 05-17 15:00:00

{"stockData":{"symbol":"301166","market":"SZ","secType":"STK","nameCN":"优宁维","latestPrice":30.7,"timestamp":1715929392000,"preClose":30.67,"halted":0,"volume":1201100,"delay":0,"floatShares":41268900,"shares":86666700,"eps":0.3185,"marketStatus":"已收盘","marketStatusCode":5,"change":0.03,"latestTime":"05-17 15:00:00","open":30.51,"high":30.95,"low":30.3,"amount":36752800,"amplitude":0.0212,"askPrice":30.72,"askSize":2,"bidPrice":30.7,"bidSize":291,"shortable":0,"etf":0,"ttmEps":0.3185,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":30.67,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":33.74,"lowLimit":27.6,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":86666668,"pbRate":1.25,"roa":"--","roe":"0.02%","epsLYR":0.47,"committee":0.665158,"marketValue":2661000000,"floatMarketCap":1267000000,"peRate":96.389321,"changeRate":0.001,"turnoverRate":0.0291,"status":0},"requestUrl":"/m/hq/s/301166/wiki","defaultTab":"wiki","newsList":[{"id":"2436994065","title":"优宁维(301166.SZ)拟10股派4.7元 于5月27日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2436994065","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2436994065?lang=zh_cn&edition=full","pubTime":"2024-05-17 18:33","pubTimestamp":1715942025,"startTime":"0","endTime":"0","summary":"智通财经APP讯，优宁维(301166.SZ)公告，公司2023年度权益分派拟：向全体股东每10股派发现金股利4.7元(含税)。除权除息日为：2024年5月27日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1122696.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435607323","title":"优宁维（301166）5月10日主力资金净卖出1059.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435607323","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435607323?lang=zh_cn&edition=full","pubTime":"2024-05-13 09:21","pubTimestamp":1715563304,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月10日收盘，优宁维报收于32.74元，下跌4.13%，换手率10.22%，成交量4.22万手，成交额1.43亿元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入1676.7万元，融资偿还1635.35万元，融资净买入41.36万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300001985.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434093745","title":"优宁维：5月9日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2434093745","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434093745?lang=zh_cn&edition=full","pubTime":"2024-05-09 19:16","pubTimestamp":1715253402,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年5月9日优宁维发布公告称公司于2024年5月9日召开业绩说明会。南京研发生产基地建设进展顺利，目前机电安装有序进行，预计今年投入使用。自募集资金于 2021年 12月到账以来，公司积极推进募投项目的实施。优宁维2024年一季报显示，公司主营收入2.72亿元，同比下降0.91%；归母净利润520.25万元，同比下降70.97%；扣非净利润35.75万元，同比下降96.66%；负债率10.25%，投资收益210.94万元，财务费用-347.91万元，毛利率19.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900034919.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434037270","title":"优宁维股东因违规交易被深圳证券交易所采取监管措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2434037270","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434037270?lang=zh_cn&edition=full","pubTime":"2024-05-09 13:00","pubTimestamp":1715230840,"startTime":"0","endTime":"0","summary":"证券之星消息，5月8日优宁维公开信息显示，优宁维股东宁波保税区嘉信麒越股权投资管理有限公司-苏州上凯创业投资合伙企业，宁波嘉信佳禾创业投资合伙企业因违规交易被深圳证券交易所创业板公司管理部采取监管措施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900020881.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434084392","title":"优宁维（301166）5月8日主力资金净买入1375.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434084392","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434084392?lang=zh_cn&edition=full","pubTime":"2024-05-09 09:10","pubTimestamp":1715217049,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月8日收盘，优宁维报收于36.89元，上涨14.07%，换手率18.83%，成交量7.77万手，成交额2.81亿元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入3000.05万元，融资偿还1360.05万元，融资净买入1640.0万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900015054.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433724958","title":"5月8日优宁维发布公告，其股东减持30.91万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724958","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433724958?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:01","pubTimestamp":1715176887,"startTime":"0","endTime":"0","summary":"证券之星消息，5月8日优宁维发布公告《优宁维:关于股东减持结果的公告》，其股东宁波保税区嘉信麒越股权投资管理有限公司-苏州上凯创业投资合伙企业、宁波嘉信佳禾创业投资合伙企业于2023年8月18日至2024年5月8日间合计减持30.91万股，占公司目前总股本的0.3567%，变动期间该股股价下跌15.41%，截止5月8日收盘报36.89元。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800040092.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433253397","title":"优宁维(301166.SZ)遭股东嘉信投资及上凯投资合计减持30.91万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433253397","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433253397?lang=zh_cn&edition=full","pubTime":"2024-05-08 20:52","pubTimestamp":1715172742,"startTime":"0","endTime":"0","summary":"智通财经APP讯，优宁维(301166.SZ)公告，公司股东嘉信投资及上凯投资减持计划已期限届满，合计减持公司股份30.91万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118987.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430229853","title":"优宁维：公司对外投资收购，主要围绕现有主营业务，寻找具有协同效应的标的企业，以实现经营业绩不断提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2430229853","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430229853?lang=zh_cn&edition=full","pubTime":"2024-04-26 18:04","pubTimestamp":1714125861,"startTime":"0","endTime":"0","summary":"投资者：尊敬的董秘你好，从国际巨头的大型公司来说，要想成长做大做强必须进行产业并购，贵公司上市2年多了，融资了大量现金，迟迟不进行并购，是找不到合适的并购公司吗优宁维董秘：投资者您好，公司对外投资收购，主要围绕现有主营业务，寻找具有协同效应的标的企业，以实现经营业绩不断提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600044215.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430249654","title":"优宁维(301166.SZ)发布一季度业绩，净利润520.25万元，下降70.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430249654","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430249654?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:07","pubTimestamp":1714118860,"startTime":"0","endTime":"0","summary":"智通财经APP讯，优宁维(301166.SZ)发布2024年第一季度报告，该公司营业收入为2.72亿元，同比减少0.91%。归属于上市公司股东的净利润为520.25万元，同比减少70.97%。归属于上市公司股东的扣除非经常性损益的净利润为35.75万元，同比减少96.66%。基本每股收益为0.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111432.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429125723","title":"优宁维（301166）2023年年报简析：增收不增利，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2429125723","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429125723?lang=zh_cn&edition=full","pubTime":"2024-04-24 06:23","pubTimestamp":1713911002,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期优宁维发布2023年年报。根据财报显示，本报告期中优宁维增收不增利，三费占比上升明显。截至本报告期末，公司营业总收入12.26亿元，同比上升2.57%，归母净利润4031.88万元，同比下降62.18%。筹资活动产生的现金流量净额变动幅度为-974.88%,原因:本期支付2022年度利润分配及归还银行贷款。证券之星价投圈财报分析工具显示：资产质量方面，公司现金资产非常健康。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400012297.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429910464","title":"优宁维最新公告：2023年净利润同比下降62%至4032万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429910464","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429910464?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:10","pubTimestamp":1713777023,"startTime":"0","endTime":"0","summary":"优宁维发布2023年年度报告，实现营业收入12.26亿元，同比增长2.57%；归属于上市公司股东的净利润4031.88万元，同比下降62.18%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200019832.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429917167","title":"优宁维(301166.SZ)发布2023年度业绩，净利润4031.88万元，下降62.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429917167","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429917167?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:03","pubTimestamp":1713776604,"startTime":"0","endTime":"0","summary":"智通财经APP讯，优宁维(301166.SZ)发布2023年年度报告，该公司营业收入为12.26亿元，同比增长2.57%。归属于上市公司股东的净利润为4031.88万元，同比减少62.18%。归属于上市公司股东的扣除非经常性损益的净利润为1229.41万元，同比减少85.59%。基本每股收益为0.47元。此外，拟向全体股东每10股派发现金红利4.7元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106538.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2413018782","title":"【异动股】千金藤素板块下挫，优宁维(301166.CN)跌1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413018782","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2413018782?lang=zh_cn&edition=full","pubTime":"2024-02-23 10:45","pubTimestamp":1708656326,"startTime":"0","endTime":"0","summary":"今日早盘，截至10:45，千金藤素板块下挫。优宁维(301166.CN)跌1.90%报29.87元，皓元医药(688131.CN)跌1.45%报34.58元，方盛制药(603998.CN)跌1.38%报9.31元，步长制药(603858.CN)跌1.06%报16.85元，云南白药(000538.CN)跌0.44%报49.76元。","market":"us","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65d806c69dfc4250c48f406c","is_publish_highlight":false,"gpt_icon":0},{"id":"2406228753","title":"优宁维(301166.SZ)发预减，预计2023年度净利润4000万元至5500万元，同比下降48.35%至62.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406228753","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2406228753?lang=zh_cn&edition=full","pubTime":"2024-01-26 16:56","pubTimestamp":1706259360,"startTime":"0","endTime":"0","summary":"优宁维披露2023年度业绩预告，公司预计归属于上市公司股东的净利润4000万元至5500万元，同比下降48.35%至62.44%;扣除非经常性损益后的净利润1400万元至2100万元，同比下降75.35%至83.57%。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-26/doc-inaevxma4619749.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-26/doc-inaevxma4619749.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-12-28","address":"上海市杨浦区控江路1690号1505室","stockEarnings":[{"period":"1week","weight":-0.1019},{"period":"1month","weight":0.1508},{"period":"3month","weight":0.1508},{"period":"6month","weight":-0.2739},{"period":"1year","weight":-0.3089},{"period":"ytd","weight":-0.2017}],"companyName":"上海优宁维生物科技股份有限公司","boardCode":"AI0051","perCapita":"3527股","boardName":"批发业","registeredCapital":"8666万元","compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":0.0384},{"period":"3month","weight":0.0895},{"period":"6month","weight":0.0223},{"period":"1year","weight":-0.0493},{"period":"ytd","weight":0.0496}],"survey":"　　上海优宁维生物科技股份有限公司是一家面向高等院校、科研院所、医院和生物医药企业等，提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务的科学服务商。公司主要产品及服务有生命科学试剂、生命科学仪器及耗材、综合技术服务。目前公司提供生命科学产品SKU约870万种，覆盖基因、蛋白、细胞、组织及动物等不同水平的研究对象，涵盖生命科学基础研究、医学基础研究、体外诊断研究、药物研发、细胞治疗研究等领域，是国内生命科学产品种类及规格最全面的供应商之一。","serverTime":1715947764687,"listedPrice":86.06,"stockholders":"11700人(较上一季度减少8.91%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"优宁维,301166,优宁维股票,优宁维股票老虎,优宁维股票老虎国际,优宁维行情,优宁维股票行情,优宁维股价,优宁维股市,优宁维股票价格,优宁维股票交易,优宁维股票购买,优宁维股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}